- Envoyer à un ami
- RSS
- google +
- Version imprimable
- Envoyer cette page par e-mail
Actualité (Les femmes)
Les flux Santé-UE relatifs à l'actualité et aux événements sont générés automatiquement selon des critères établis par la Commission européenne. Ils peuvent contenir des erreurs de classification.
UNFPA - UNFPA Drives Family Planning Innovation to Reach World’s Most Marginalized, at Major Women’s Health Conference » unfpa.org
UNITED NATIONS, New York —UNFPA, the United Nations Population Fund, will launch two new initiatives that will increase access to family planning and improve maternal health in some of the most-hard[...]European Medicines Agency reiterates PRAC recommendation for Diane 35 and generics» europa.eu
Following the conclusion of the Pharmacovigilance Risk Assessment Committee (PRAC) that the benefits of Diane 35 and its generics outweigh the risks in a specific patient group, the French National A[...]Benefits of Diane 35 and generics outweigh risks in specific patient group » europa.eu
The European Medicines Agency?s Pharmacovigilance Risk Assessment Committee (PRAC) has concluded that the benefits of Diane 35 (cyproterone acetate 2 mg, ethinylestradiol 35 micrograms) and its gener[...]2013 is the beginning of a dramatic shift in women’s health»
Millions of girls in the world’s poorest countries to be immunised against the human papilloma virus (HPV) thanks to GAVI negotiating low price for vaccine
World Immunisation week (20-27 April) – New vaccine scheduler»
A new interactive platform of vaccination schedules for individual European countries and for specific age groups has been developed by the European Centre for Disease Prevention and Control (ECDC), with the Groupe d’Etudes en Preventologie.
Research Headlines - Developing a new screening test for a life-threatening maternal condition» europa.eu
In countries with well-developed healthcare systems, dying as a direct result of a condition brought on by pregnancy is a remote and shocking possibility. Nevertheless, one such condition, pre-eclamp[...]Examining the effects of breast cancer radiotherapy» europa.eu
Breast cancer is the most frequent cancer in women worldwide. The highest rate is in North America, with Europe close behind. Most women diagnosed with breast cancer receive radiation to help prevent[...]Amnesty International urges EU Institutions to end Female Genital Mutilation» epha.org
Amnesty International Ireland, together with other 15 organisations from all across Europe, has been running the END Female Genital mutilation (FGM) European Campaign since 2009 to promote awareness [...]The study to identify and map existing data and resources on sexual violence against women in the EU - Just Published - EU Bookshop» europa.eu
The study to identify and map existing data and resources on sexual violence against women in the EU[...]Women...Learn about ways to decrease your chances of heart disease, heart attack and stroke» escardio.org
Although studies show a significant improvement in Europe's heart health, the number of young women having heart attacks is on the rise. In conjunction with International Women's Day (8 March 2013), [...]IPPF Statement: Elimination and prevention of all forms of violence against women and girls» ippfen.org
Share this page with a friend by filling out the information below and then pressing "Send". Tick here if it is ok to contact you in future 146 rue Royale, Brussels 1000, Tel: +32 (0)2 250 09 50[...]Now available: Concept document - Experts Workshop on the proposal of an EU accreditation scheme for breast cancer services/European breast cancer guidelines» europa.eu
Organised by the JRC-IHCP Cancer Policy Support Group[...]
European Institute for Women's Health issues new factsheet on 'women and cardiovascular diseases in the EU'»
Traditionally regarded as a male disease, cardiovascular disease (CVD) is the number one killer of women worldwide. It also is a major cause of serious illness and disability, costly to healthcare systems and destroying women’s quality of life